
machine in 1987, when the Korea’s contact lens business was in its embryonic stage.
Dreamcon’s top priority in manufacturing its contact lenses as an eyesight correction medical device is user’s health and safety, and thus it established its in-house R&D center in 2009 to devote itself to developing new products and enhancing its core technical competence. As a result of these efforts, it obtained a seven-year expiry date for all of its products from KFDA, the first and only in the industry. Also, it succeeded in developing the world’s first nano anti-bacterial lens and acquiring the patent for a special method called “Plusierus,” along with six patent registrations, eight trademark rights and 11 design rights. With the commitment to quality, it has 11 international certifications such as ISO9001, ISO13485, CE, the U.S. FDA, Ministry of Health, Labor and Welfare of Japan, CFDA for China, Thai FDA, Russia registration and Gost-R for Russia.
In particular, all of the company’s color and contact lenses are manufactured by a special
method called “Plusierus,” which capsulates pigments and embeds the capsulated pigments between the layers called HEMA to keep the eyes safe and comfortable. Dreamcon’s technological capacity was highly recognized as its soft contact lens has been selected as a ‘World-Class Product’ by ‘Korea’s Ministry of Trade, Industry and Energy among contact lens manufacturers in Korea. Dreamcon’s core technology is expected to play a key role in helping enhance the company’s presence in the global market. Dreamcon is regularly participating, at least four times annually, in global exhibitions to find new buyers.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods